First Time Us Pharmaceuticals (India) Private Limited, a active foreign private limited company, was established on 10 June 2013 in Navi Mumbai, Maharashtra, India. Engaging in medical equipment retail & distribution within the professional, scientific and technical sector, it holds CIN: U74999MH2013FTC244256. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹6.00 Cr and a paid-up capital of ₹4.37 Cr.
It upholds a compliant status. Employing 48 professional, Its leadership includes Vibhor Shirish Misar (Director), Manesh Ashok Dixit (Director), Sachin Janardan Bhusari (Nominee Director). Past directors included Vibhor Shirish Misar, Priyanka Shirishkumar Misar, Ashok Arjun Mhaske. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at C-112, Pawane, T.T.C Industrial Area, M.I.D.C.,, Navi Mumbai, Maharashtra, 400705.
U74999MH2013FTC244256
244256
10 June 2013
₹6.00 Cr
₹4.37 Cr
Roc Mumbai
Unlisted
Active
Explore comprehensive insights into First Time Us Pharmaceuticals (India) Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Vibhor Shirish Misar | Director | 18 Dec 2013 | Current |
| Manesh Ashok Dixit | Director | 10 Jun 2013 | Current |
| Sachin Janardan Bhusari | Nominee Director | 13 Aug 2025 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Additional Director | 30 Sep 2014 | Past |
| Pramod Abcsdd | Director | 29 Jul 2025 | Past |
| Pramod Abcsdd | Additional Director | 30 Sep 2015 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
First Time Us Pharmaceuticals (India) Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 42.57% increase. The company also saw a substantial improvement in profitability, with a 661.23% increase in profit. The company's net worth Soared by an impressive increase of 29.01%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, First Time Us Pharmaceuticals (India) had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
First Time Us Pharmaceuticals (India) has a workforce of 48 employees as of Mar 27, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of First Time Us Pharmaceuticals (India), offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped First Time Us Pharmaceuticals (India)'s trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Sachin Janardan Bhusari was appointed as a Nominee Director was appointed as a Nominee Director on 13 Aug 2025 & has been associated with this company since 4 months 6 days . was completed.
The activity First Time Us Pharmaceuticals (India) Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was completed.
First Time Us Pharmaceuticals (India) Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Mumbai. was recorded as a recent event.
Progress on Vibhor Shirish Misar was appointed as a Director was appointed as a Director on 18 Dec 2013 & has been associated with this company since 11 years 11 months . was documented.
Progress on Manesh Ashok Dixit was appointed as a Director was appointed as a Director on 10 Jun 2013 & has been associated with this company since 12 years 6 months . was documented.
Progress on First Time Us Pharmaceuticals (India) Private Limited was registered on 10 Jun 2013 with Roc Mumbai & aged 12 years 6 months as per MCA records. was documented.
The CIN of First Time Us Pharmaceuticals (India) Private Limited is U74999MH2013FTC244256.
First Time Us Pharmaceuticals (India) Private Limited is headquartered at C-112, Pawane, T.T.C Industrial Area, M.I.D.C.,, Navi Mumbai, Maharashtra, 400705.
First Time Us Pharmaceuticals (India) Private Limited was incorporated on 10 June 2013.
The current directors of First Time Us Pharmaceuticals (India) Private Limited are
The primary industry of First Time Us Pharmaceuticals (India) Private Limited is Professional, Scientific And Technical.
First Time Us Pharmaceuticals (India) Private Limited is unlisted.
The authorized capital of First Time Us Pharmaceuticals (India) Private Limited is ₹6.00 Cr, and the paid-up capital is ₹4.37 Cr.
The compliance status of First Time Us Pharmaceuticals (India) Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
_PRIVATE_LIMITED.webp)
Company Details
+91-XXXXXXXXXX